DFO
Duquesne Family Office Portfolio holdings
AUM
$3.91B
This Quarter Return
+13.48%
1 Year Return
+47.2%
3 Year Return
+280.12%
5 Year Return
+423.68%
10 Year Return
+3,456.84%
AUM
$2.85B
AUM Growth
+$2.85B
(+1.2%)
Cap. Flow
-$320M
Cap. Flow
% of AUM
-11.21%
Top 10 Holdings %
Top 10 Hldgs %
64.8%
Holding
95
New
31
Increased
11
Reduced
19
Closed
22
Top Buys
| 1 |
Natera
NTRA
|
$202M |
| 2 |
SPDR S&P Regional Banking ETF
KRE
|
$116M |
| 3 |
Broadcom
AVGO
|
$41.4M |
| 4 |
Ascendis Pharma
ASND
|
$39.6M |
| 5 |
nVent Electric
NVT
|
$31.7M |
Top Sells
| 1 |
Vistra
VST
|
$265M |
| 2 |
Microsoft
MSFT
|
$154M |
| 3 |
Kinder Morgan
KMI
|
$91.5M |
| 4 |
GE Vernova
GEV
|
$68.3M |
| 5 |
Mid-America Apartment Communities
MAA
|
$64.4M |
Sector Composition
| 1 | Technology | 22.21% |
| 2 | Healthcare | 21.76% |
| 3 | Consumer Discretionary | 15.87% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
First Citizens BancShares
FCNCA
$25.6B
| $9.54M | 0.32% | +5,183 | New | +$9.54M |
|
52
YPF
YPF
$12B
| $9.12M | 0.31% | 430,100 -208,335 | -33% | -$4.42M |
|
53
ARS Pharmaceuticals
SPRY
$1.15B
| $7.79M | 0.26% | +536,900 | New | +$7.79M |
|
|
54
GE Vernova
GEV
$167B
| $7.46M | 0.25% | 29,250 -267,818 | -90% | -$68.3M |
|
|
SLN
55
Silence Therapeutics
SLN
$227M
| $7.04M | 0.24% | 387,400 | – | – |
|
56
Arcellx
ACLX
$3.85B
| $6.19M | 0.21% | 74,100 | – | – |
|
57
TC Energy
TRP
$54.1B
| $5.49M | 0.19% | +115,400 | New | +$5.49M |
|
58
Starbucks
SBUX
$100B
| $5.1M | 0.17% | +52,305 | New | +$5.1M |
|
59
XPO
XPO
$15.3B
| $5M | 0.17% | +46,500 | New | +$5M |
|
60
Vaxcyte
PCVX
$4B
| $4.91M | 0.17% | +42,965 | New | +$4.91M |
|
61
Western Digital
WDC
$27.9B
| $4.88M | 0.17% | +71,405 | New | +$4.88M |
|
62
NewAmsterdam Pharma
NAMS
$2.71B
| $4.77M | 0.16% | +287,535 | New | +$4.77M |
|
63
Ultragenyx Pharmaceutical
RARE
$2.89B
| $4.75M | 0.16% | +85,445 | New | +$4.75M |
|
|
BCYC
64
Bicycle Therapeutics
BCYC
$511M
| $4.3M | 0.15% | 190,200 | – | – |
|
65
Arm
ARM
$147B
| $3.09M | 0.1% | +21,610 | New | +$3.09M |
|
66
IHS Holding
IHS
$2.43B
| $2.3M | 0.08% | 770,310 | – | – |
|
67
TriSalus Life Sciences
TLSI
$260M
| $1.97M | 0.07% | 426,921 | – | – |
|
68
Palantir
PLTR
$372B
| $1.55M | 0.05% | 41,710 -728,255 | -95% | -$27.1M |
|
69
Insmed
INSM
$28.8B
| $1.46M | 0.05% | 20,000 | – | – |
|
70
Nurix Therapeutics
NRIX
$714M
| $993K | 0.03% | 44,200 | – | – |
|
71
Invivyd
IVVD
$204M
| $583K | 0.02% | 571,425 | – | – |
|
72
Joby Aviation
JOBY
$12.1B
| $113K | ﹤0.01% | 22,492 | – | – |
|
73
Apple
AAPL
$3.45T
| – | – | -24,400 | Closed | -$5.14M |
|
74
AES
AES
$9.64B
| – | – | -314,750 | Closed | -$5.53M |
|
75
Arista Networks
ANET
$172B
| – | – | -52,275 | Closed | -$18.3M |
|